P3 Health Partners Profit Margin 2020-2024 | PIII
Current and historical gross margin, operating margin and net profit margin for P3 Health Partners (PIII) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. P3 Health Partners net profit margin as of September 30, 2024 is -6.95%.
| P3 Health Partners Annual Profit Margins |
|---|
| P3 Health Partners Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.077B | $1.266B |
| P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $8.263B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.580B | 174.01 |
| Hims & Hers Health (HIMS) | United States | $5.276B | 134.17 |
| Enovis (ENOV) | United States | $2.580B | 17.49 |
| Privia Health (PRVA) | United States | $2.530B | 210.80 |
| IRhythm Technologies (IRTC) | United States | $2.313B | 0.00 |
| Azenta (AZTA) | United States | $2.227B | 111.05 |
| Omnicell (OMCL) | United States | $2.043B | 66.83 |
| Clover Health Investments (CLOV) | United States | $1.684B | 0.00 |
| 10x Genomics (TXG) | United States | $1.609B | 0.00 |
| Schrodinger (SDGR) | United States | $1.484B | 0.00 |
| Phreesia (PHR) | United States | $1.098B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.701B | 0.00 |
| Standard BioTools (LAB) | United States | $0.603B | 0.00 |
| Talkspace (TALK) | United States | $0.559B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.518B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.491B | 85.00 |
| Health Catalyst (HCAT) | United States | $0.466B | 0.00 |
| Pulmonx (LUNG) | United States | $0.254B | 0.00 |
| TruBridge (TBRG) | United States | $0.239B | 69.61 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.205B | 0.00 |
| American Well (AMWL) | United States | $0.123B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.115B | 0.00 |
| HeartBeam (BEAT) | United States | $0.075B | 0.00 |
| 111 (YI) | China | $0.052B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.038B | 0.00 |
| Movano (MOVE) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.010B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |